STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1602 by analyst upside · 2026-06-27
NUTX
Nutex Health Inc.
Healthcare · Market Cap $1B · P/E 12.2x
ANALYST PRICE TARGET
+41.5%
implied upside to consensus target
Current Price $166.4
Consensus Target $235.5
Bull Target $300.0
Bear Target $175.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
0
Sell
0
52-Week Low $77.21
52-Week High $193.07
YTD Return +12.3%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 12.2x
Forward P/E 8.2x
EPS (TTM) $13.67
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $880M
Profit Margin 11.0%
52-WEEK RANGE
52-Week Low $77.21
52-Week High $193.07
Current Price $166.4
Bear Target $175.0
Bull Target $300.0
● Now $166.4 ● Target $235.5
TRADING DATA
Avg Volume 156K
YTD Return +12.3%
Analyst Count 4
Consensus Buy
Upside to Target +41.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Nutex Health Inc. (NUTX) is currently trading at $166.4 with a Wall Street consensus price target of $235.5, implying potential upside of 41.5% over the next 12 months. 4 analysts currently cover NUTX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $300.0, while the most cautious has a target of $175.0.

NUTX operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 12.3% year-to-date and is currently trading near the upper end of its 52-week range of $77.21 – $193.07.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for NUTX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Lake Street ● Initiated
Buy 2026-06-02 27% win rate (11 calls)
Maxim Group — Reiterated
Buy → Buy 2025-08-26 28% win rate (40 calls)
Benchmark reit
Buy → Buy 2025-07-10 Building track record
Maxim Group — Reiterated
Buy → Buy 2025-05-20 28% win rate (40 calls)
Benchmark — Reiterated
Buy → Buy 2025-05-15 Building track record
Benchmark — Reiterated
Buy → Buy 2025-04-09 Building track record
Maxim Group — Reiterated
Buy → Buy 2025-04-08 28% win rate (40 calls)
Maxim Group — Reiterated
Buy → Buy 2025-02-13 28% win rate (40 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
54
out of 100
Coverage depth
12/30
Consensus clarity
15/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →